Brief: Brickell Biotech Reports Q2 2022 Results

Fresh Tracks Therapeutics

11/08/2022 22:33

Aug 11 (Reuters) - Brickell Biotech Inc  BBI.O :
    * BRICKELL BIOTECH REPORTS SECOND QUARTER 2022 FINANCIAL
RESULTS
AND PROVIDES CORPORATE UPDATE
    * BRICKELL BIOTECH INC - EXPECTS ITS CASH AND CASH
EQUIVALENTS AS
OF JUNE 30, 2022, WILL SUPPORT ITS OPERATIONS FOR AT LEAST THE
NEXT 12 MONTHS
    * BRICKELL BIOTECH INC - QTRLY LOSS PER SHARE $0.01

Source text for Eikon:  ID:nGNX5hdbfb 
Further company coverage:  BBI.O 

 ((Reuters.Briefs@thomsonreuters.com;))